Growing popularity of legalizing the use for medical marijuana seems to have created another breakthrough with the latest discovery that it could lead to relieving patients suffering from multiple sclerosis (MS).
This latest development was published in the journal Neurology, and is based on a review made by a team of researchers from the American Academy of Neurology who conducted the study on the effects of using medical marijuana. However, according to a report from The Boston Globe, they immediately dismissed the effects of marijuana to give relief of Parkinson’s disease and epilepsy or seizures.
Dr. Barbara Koppel, who heads the study and is a neurologist from New York Medical College in New York, disclosed that the marijuana plant contains cannabinoids, which provide relief of multiple sclerosis and with fewer side effects than tetrahydrocannabinol (THC), the primary component that causes the feeling of being high. However, it was suggested to take the compound in a pill or spray form rather than smoke it, because it is harder to measure the exact amount of active compound that the patient could get when inhaled.
The National Multiple Sclerosis Society welcomes this new development and puts its support on the basis of fulfilling the rights of MS patients who want to try medical marijuana. They also advised their members to coordinate with health providers in accessing marijuana because it was not specifically determined in the study if smoking marijuana is helpful or safe for the treatment of MS.